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Burden of Brucellosis in the Middle East: 29 
A Systematic Review 30 
 31 
SUMMARY 32 
A systematic review of studies providing frequency estimates of brucellosis in humans and ruminants and risk 33 
factors for Brucella spp. seropositivity in humans in the Middle East was conducted to collate current 34 
knowledge of brucellosis in this region. Eight databases were searched for peer-reviewed original Arabic, 35 
English, French and Persian journal articles; the search was conducted on June 2014. Two reviewers evaluated 36 
articles for inclusion based on pre-defined criteria. Of 451 research articles, only 87 articles passed the 37 
screening process and provided bacteriological and serological evidence for brucellosis in all Middle Eastern 38 
countries. Brucella melitensis and B. abortus have been identified in most countries in the Middle East, 39 
supporting the notion of widespread presence of Brucella spp. especially B. melitensis across the region. Of 40 
the 87 articles, 49 were used to provide evidence of the presence of Brucella spp. but only 11 provided new 41 
knowledge on the frequency of brucellosis in humans and ruminants or on human risk factors for 42 
seropositivity and were deemed of sufficient quality. Small ruminant populations in the region show 43 
seroprevalence values that are among the highest worldwide. Human cases are likely to arise from 44 
subpopulations occupationally exposed to ruminants or from the consumption of unpasteurized dairy 45 
products. The Middle East is in need of well-designed observational studies that could generate reliable 46 
frequency estimates needed to assess the burden of disease and to inform disease control policies. 47 
 48 
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 50 
 51 
 52 
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INTRODUCTION 55 
Brucellosis is a zoonotic disease which affects a wide range of animals including domestic livestock. It is 56 
caused by members of the genus Brucella; among the ten known species of Brucella; B. melitensis, B. 57 
abortus, B. suis, B. canis and B. ceti have been isolated in human cases in addition to their specific animal 58 
hosts [1, 2, 3, 4]. Although accurate estimates of human incidence are lacking, largely because of under- 59 
reporting and misdiagnosis [5], brucellosis is considered one of the most common bacterial zoonoses 60 
worldwide [6].  61 
In endemic areas, brucellosis is responsible for significant economic losses to livestock production due to 62 
abortions, reduced milk yield and infertility in addition to the public health burden [7]. The disease is 63 
transmitted to humans via consumption of un-heat treated milk and dairy products from infected animals and 64 
through direct contact with afterbirths and aborted materials. As a result, individuals with occupational 65 
livestock contact in endemic areas, including farmers, abattoir workers, shepherds and veterinarians are at 66 
high risk [8]. The symptoms of human infection are non-specific, but the majority of patients with the acute 67 
form, present with fever, malaise, anorexia, headache, arthralgia, and backache. Persistent and recurrent fever 68 
is the most common clinical symptom in sub-acute cases. A small proportion of cases may develop 69 
complications including arthritis, endocarditis, spondylitis, sacroiliitis, osteomyelitis and meningoencephalitis 70 
[9, 10]. 71 
Infected livestock are the source of the vast majority of human cases; therefore, prevention of human 72 
brucellosis is dependent on the control of the disease in livestock. This has been achieved with varying 73 
degrees of success using a combination of vaccination, test and removal of positive animals and quarantine / 74 
animal movement controls [11]. Cattle brucellosis caused primarily by B. abortus has been successfully 75 
eradicated from several countries including Japan, Canada, some European countries, Australia and New 76 
Zealand [12].  However, the control of B. melitensis in small ruminants is more challenging than that of B. 77 
abortus, potentially as a result of its higher infectivity as well as the characteristics of the livestock systems 78 
where it is endemic including increased mobility of small ruminant populations compared to large ruminants 79 
[12, 13]. Different control strategies have been recommended by the Food and Agriculture Organisation 80 
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(FAO) depending on the flock-/herd-level seroprevalence, therefore reliable disease frequency estimates are of 81 
great importance to inform and monitor the control programme. In low-prevalence areas (<2%) test and 82 
slaughter of positive animals accompanied by sanitary measures is recommended. In settings where 83 
prevalence ranges between 2% and 10% FAO advocates vaccination of young animals, non-compulsory 84 
vaccination of adult animals and test-and slaughter of infected animals. In regions where prevalence is higher 85 
than 10%, mass vaccination of all livestock is proposed as the optimal control strategy until a significant 86 
prevalence reduction is achieved and the strategy can be revised [12]. The appropriate strategy also depends 87 
on the socioeconomic context, the applied surveillance system, the policy set by the competent authorities as 88 
well as the baseline level of infection. Ultimately, decisions on whether to prioritize brucellosis control over 89 
other diseases should ideally be informed by estimates of the human health burden expressed as Disability 90 
Adjusted Life Years (DALYs) and measures of monetary impact i.e. economic losses due to human illness 91 
and decreased livestock productivity [14]. The assumed high burden of the disease, particularly in low-income 92 
countries, is not matched by the attention it receives from health systems worldwide and as a result brucellosis 93 
has been included in the WHO's list of Neglected Zoonotic Diseases [6] Brucellosis is a major public health 94 
problem in the Middle East, Mediterranean region, and parts of Asia, Africa and Latin America [15]. In this 95 
paper we focus on the Middle East, a region where brucellosis is assumed to be among the zoonoses with 96 
highest burden [16]. The region includes 15 countries; Bahrain,  Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, 97 
Oman, Palestine, Qatar, Saudi Arabia, Syria, United Arab Emirates, Yemen, and Israel [17] (Fig. 1a). Most of 98 
these countries have many similarities regarding livestock management systems, environmental conditions 99 
and culture [16]. Brucellosis is receiving increasing attention in the Middle East; some countries such as 100 
Egypt and Oman are implementing mass vaccination programs for small and large ruminants whereas others 101 
e.g. Iran, Iraq and Israel are adopting mass vaccination of small ruminants Fig. 1b. The aim of this study was 102 
to systemically identify, evaluate and summarize relevant published data on the presence and frequency of 103 
ruminant and human brucellosis in the Middle Eastern countries as well as on the strength of association 104 
between potential risk factors and Brucella. spp. seropositivity in humans. 105 
  106 
5 
 
METHODS 107 
Systematic Review Protocol 108 
A systematic review was conducted using a predefined protocol based on Cochrane [18] and PRISMA [19] 109 
guidelines. The protocol includes four main steps; i) literature search to identify potential articles of relevance, 110 
ii) screening for relevance, iii) quality assessment and iv) data extraction. Figure 2 summarizes the steps of 111 
the protocol with the number of papers that fulfilled the necessary criteria at each step. 112 
 113 
Search Strategy and identification 114 
Eight electronic data bases;  BioMed Central Journals, CAB Direct (CABI), Cochrane Library - Cochrane 115 
Database of Systematic Reviews (Wiley), ScienceDirect, ERIC plus Text (ProQuest), IBSS (CSA), PubMed, 116 
and Web of Science (ISI) Zetoc, were searched using the following terms: 117 
1) Brucellosis OR Malta fever OR Brucella OR “Brucella melitensis” OR “Brucella abortus”.  118 
AND 119 
2) Middle East OR (Bahrain, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Oman, Palestine, Qatar, Saudi 120 
Arabia, Syria, United Arab Emirates, Yemen, Israel).  121 
AND 122 
3) Prevalence OR Incidence OR Burden OR Risk AND Factors.  123 
The search was conducted on June 2014 for papers published since the original search. No time limits were 124 
set.  125 
Screening Process 126 
All references were imported to EndNote (Thomson Reuters) and duplicated articles were excluded. The 127 
retrieved abstracts were screened by the primary author for entry into the next stage (quality assessment) 128 
based on the following inclusion criteria: 129 
1. The reported research is original and studies a human or animal population in one or more of the Middle 130 
Eastern countries. 131 
AND 132 
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2. The article is published in a peer reviewed section of a journal.  133 
AND 134 
3. The article is written in Arabic, English, French or Persian languages. 135 
AND 136 
4. The research provides: 137 
a. Estimates of the frequency ((sero)-prevalence and/or incidence) of Brucella spp. infection in domestic 138 
ruminants and/or humans. 139 
AND  140 
b. Estimates of the strength of association between Brucella spp. infection in domestic ruminants and/or 141 
humans. 142 
For articles that met the primary inclusion criteria or articles where the relevance could not be determined by 143 
reading the abstract alone; full texts were retrieved and the article was subjected to a quality assessment and 144 
data extraction.       145 
                                                                                                                                                         146 
Quality assessment and Data extraction 147 
Two reviewers independently assessed the quality of the articles based on a set of criteria adapted from 148 
Cochrane guidelines [18], and Downs & Black guidelines for cross-sectional studies [20]. Reviewers were 149 
firstly asked to specify the type of study, whether it was descriptive or analytical (i.e. involving an element of 150 
comparison across groups). Studies that were limited to the description of the characteristics of a series of 151 
cases (case reports) were excluded.  Reviewers were asked a series of questions to summarise the objectives, 152 
study design, study population, sampling strategy, diagnostic test/s performed, statistical methods used and 153 
main outcomes of the study. These general questions were followed by a series of questions specific for each 154 
study type and to which reviewers could answer “yes”, “no” or “unclear”.  155 
Selected studies were appraised by the two reviewers against the following five criteria and rated as “high 156 
quality” studies when all five criteria were met: 157 
1. The type of study design was clear from the information provided; 158 
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2. Sampling strategy was clearly described and the study population was  considered fairly representative 159 
of the target population; 160 
3. The study was not deemed to have high potential for selection bias; 161 
4. Diagnostic tests used were those recommended by the World Organisation for animal Health (OIE) in 162 
the study species [7]; given that no time limit was set in the search process, OIE and WHO 163 
recommendations at the time when the study was conducted were considered. 164 
5. The vaccination status of the study population was stated.  165 
When provided, estimates of the frequency of infection (incidence or prevalence) and of the strength of 166 
association (relative risks or odds ratios) where extracted.  167 
Each reviewer extracted data independently using a data extraction form prepared by the primary author. 168 
Disagreements between reviewers were discussed in detail between them and resolved by consensus. The 169 
quality assessment checklist and data extraction forms are available upon request from the primary author. 170 
 171 
Data management 172 
Studies considered to be of “high quality” were grouped according to whether they investigated the frequency 173 
of brucellosis or risk factors for infection. Because of the heterogeneity within each group of studies in terms 174 
of study design, geographical areas, human or ruminant subpopulations under study and sample sizes, no 175 
statistical tests for heterogeneity or quantitative meta-analysis were performed; instead data were extracted, 176 
summarized and organized in a qualitative manner. 177 
Studies that passed the initial screening but did not fulfil the quality assessment criteria and were therefore 178 
deemed not to be of sufficient quality to generate unbiased estimates of frequency of disease or strength of 179 
association for human seropositivity were used to summarize available evidence of the presence of Brucella 180 
spp. in different host populations in the Middle East, where appropriate. 181 
  182 
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RESULTS 183 
Searching 184 
The initial search revealed 681 research articles, after removing duplicates 451 research articles remained, 185 
among these 23, 405, 3 and 20 were written in Arabic, English, French and Persian languages, respectively. 186 
Abstract screening was then performed and articles were excluded when they reported studies that were not 187 
carried out in one or more of the Middle Eastern countries (95 articles excluded), if they were not original 188 
research articles (114 articles excluded), if they were published in non-peer-reviewed journals (65 articles 189 
excluded) and if they did not provide estimates of brucellosis frequency in humans or domestic ruminants or 190 
potential risk factors for human seropositivity (90 articles excluded). A total of 87 articles (5 Arabic, 77 191 
English, 5 Persian) met the primary eligibility criteria. 192 
 193 
Quality assessment  194 
During the quality assessment 76 articles were excluded for not fulfilling all five quality criteria listed in the 195 
quality assessment and data extraction part of the methods. Eighteen of studies were excluded because they 196 
were descriptive case-series, 43 studies were excluded due to unclear study design or non-representative 197 
sampling therefore deemed to have high potential for selection bias. In five studies, the diagnostic tests used 198 
were not those recommended by WHO/OIE in the study species. Furthermore, in 10 studies the authors did 199 
not mention clearly whether the sampled animals were vaccinated or not, which may lead to inaccurate 200 
seroprevalence estimates. Of these 76 articles, 49 were retained and used to provide evidence of the presence 201 
of Brucella spp. in different ruminant hosts in Middle Eastern countries (Table 1). The range of the years of 202 
publication was 1974–2014 with a median of 2005. At least one B. melitensis biovar (1, 2, 3) was identified in 203 
each country and at least one B. abortus biovar (1, 2, 3, 9) was identified in nine of the 15 countries supporting 204 
the widespread presence of Brucella spp. especially B. melitensis across the region. Moreover, B. suis biovar 205 
1 was isolation from cattle in Egypt [25]. Only 11 articles were considered of sufficient quality and were used 206 
to provide frequency estimates in humans and ruminants or information on risk factors for brucellosis in 207 
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humans. Table 2 describes the features of the eleven included studies. The number of papers that passed the 208 
quality assessment step by country is presented in Figure 3. 209 
 210 
Frequency of brucellosis in humans 211 
The frequency of brucellosis in humans was investigated in many of the Middle Eastern countries but only 212 
one study [6] fully met the quality criteria. The study described a population-based surveillance for patients 213 
with acute febrile illness in Egypt and estimated an annual incidence of brucellosis at 64 and 70/100 000 214 
population in 2002 and 2003, respectively. 215 
 216 
Seroprevalence of brucellosis in ruminants 217 
A considerable number of studies assessed the frequency of brucellosis in different ruminant sub-populations 218 
in the Middle East. Four studies met the inclusion criteria; three in Egypt and one in Jordan. Table 3 219 
summarises the findings of those studies. Sheep, goat, cattle and buffaloes were the studied species, and in all 220 
cases frequency of infection was estimated as seroprevalence.  221 
In Jordan, seroprevalence in Awassi sheep in the Northern part of the country was estimated at 2.2% (95% CI: 222 
0.5 - 3.5) and 45% (95% CI: 32- 58) at individual animal and flock levels, respectively, in 2000/2001 [29]. In 223 
Egypt, prevalence estimates for different livestock species are available for Kafr el-Sheikh Governorate (the 224 
largest governorate of the Nile Delta region) and for the Upper Egypt region. In Upper Egypt, true 225 
seroprevalence was estimated to be 1.16 (95%CI: 1.05-1.27) in sheep, 0.44 (95%CI: 0.34-0.54) in goats, 0.79 226 
(95%CI: 0.71-0.87) in cows and 0.13 (95%CI: 0.08-0.18) in buffaloes. These estimates were obtained from a 227 
study using secondary data for the period 2005-2008 in 7 governorates of Upper Egypt [51]. In Kafr el- 228 
Sheikh Governorate, a study conducted in 2008 [52] estimated true prevalence to be 12.2% (95%CI: 8.4-16.0) 229 
in individual sheep, 11.3% (95%CI: 7.8 - 14.8)  in individual goats, 41.3% (95%CI: 26.1-56.7) in “village 230 
flocks”, 12.2% (95%CI: 7.0 - 13.3) in milk tanks from cows and 11.3% (95%CI: 7.8 - 14.8) in milk tanks 231 
from buffaloes. A small study conducted in one single village in another governorate of the Nile Delta 232 
(Menufiya) estimated that 11% (95% CI: 3.06-18.4) of unvaccinated individual cows and buffaloes had 233 
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detectable antibodies in milk and that 15.5% (95% CI: 6.61% to 24.7%) of households keeping cows or 234 
buffaloes had at least one positive animal [53].  235 
 236 
Risk factors associated with human brucellosis in the Middle East  237 
The review identified six studies that measured the strength of association between potential risk factors and 238 
human brucellosis in the Middle East. All of them were case-control studies and were conducted in in Iran, 239 
Saudi Arabia, Yemen, Jordan and Egypt (2 studies). Details of these studies are summarized in Table 4 and 240 
the studied risk factors are summarized below. 241 
 242 
Consumption of dairy products 243 
Generally, the consumption of unpasteurized dairy products was a statistically significant risk factor for 244 
seropositivity in the Middle East. The study in Saudi Arabia revealed that consumption of unpasteurised milk 245 
(OR: 3.8, 95% CI 2.2-6.4) and buttermilk (dairy product locally known as laban) (OR: 3.0, 95% CI 1.2-7.6) 246 
were significant risk factors for infection. The consumption of unpasteurised dairy products was also a risk 247 
factor for infection in Yemen and Iran, with Iran sheep-derived products posing the greatest risk in the study 248 
conducted in this country. In Jordan, the consumption of raw feta cheese (OR: 2.8, 95% CI: 1.4–5.6) was 249 
positively associated with brucellosis, whilst the consumption of cows’ milk (OR: 0.4, 95% CI: 0.2–0.8) and 250 
the consumption of boiled feta cheese (OR: 0.4, 95% CI: 0.2-0.8) decreased the risk of brucellosis [50]. In 251 
Egypt eating ice cream from street venders (OR: 2.4, 95% CI: 1.2 – 4.6) was a risk factor for the disease. 252 
 253 
Occupational exposure 254 
Among exposures not associated with the foodborne route, assisting with animal parturition was a significant 255 
risk factor for infection (OR: 3.6, CI 2.1 – 6.1). Farmers (OR: 2.5, 95% CI: 1.4-4.5), shepherds (OR: 7.8, 95% 256 
CI: 1.0-61) and microbiologists (OR: 24.5, 95% CI: 2.9-204) were the groups at highest occupational risk of 257 
acquiring brucellosis in Yemen, [46]. The study in Tanta Fever Hospital in Egypt (2003) identified contact 258 
with sheep (OR: 6.2, 95% CI: 1.9 – 20.4), high-risk occupation (OR: 4.4, 95% CI: 1.3-14.5) and history of 259 
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having an aborted animal (OR: 3.5, 95% CI: 1.3 – 9.1) as significant risk factors for human brucellosis [48].  260 
Similarly, the study in Alexandria Fever Hospital in Egypt identified direct contact with goats (OR:  3.2, 261 
95%CI: 1.2 – 8.7) and occupations dealing with animals (OR: 2.4, 95% CI: 1.2 – 4.9) as significant risk 262 
factors [49]. The case-control study from Jordan revealed that milking small ruminants was a risk factor for 263 
infection (OR: 3.5, 95%CI: 1.5–8.4). Finally, the study in Iran also showed that the existence of another case 264 
of brucellosis in the home (OR: 7.55, 95% CI: 3.9- 14.6) was a major risk factor for infection. 265 
 266 
Discussion 267 
Brucellosis is considered endemic in most Middle Eastern countries where it is assumed to impose a 268 
considerable burden as a result of human disease and impaired livestock productivity [31, 32].  Our work 269 
aimed to systematically review available data regarding Brucella spp. presence and frequency estimates in 270 
humans and ruminants and associations between potential risk factors and human seropositive status in the 271 
Middle East. Although the primary search revealed 451 studies, after assessing their relevance, only 87 272 
articles met the primary inclusion criteria and 49 of these provided evidence relevant for this review. Using 273 
strict quality criteria, only 11studies were deemed of sufficient quality to provide reliable seroprevalence 274 
estimates that could eventually be used to quantify the burden of brucellosis in the region or data to inform 275 
disease prevention programmes prioritizing populations based on specific risk factors. 276 
Most studies were excluded due to incomplete or unclear description of the design, or a design that was 277 
unlikely to generate unbiased estimates, including prevalence studies carried out using non-probabilistic 278 
sampling, studies comparing seroprevalence in purposively selected subpopulations without consideration of 279 
potential biases and studies where clustering of individual animals within herds was ignored. Most of the 280 
articles deemed of sufficient quality were produced in the last 15 years (9 of 11) and the other two articles 281 
were produced in the 1990s; moreover, 7 of 11 articles were collaborative work between European or US and 282 
Middle Eastern researchers. This reflects the relatively modest and recent development of epidemiological 283 
research in the region and the importance of international collaboration. 284 
 285 
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Another critical issue with some studies was the use of diagnostic tests that are not recommended by the 286 
WHO/OIE for the host species being studied making the reliability of the obtained estimates questionable. 287 
Uncertainty with regard to the sensitivity and specificity of diagnostic tests being used hinders adjustment of 288 
observed apparent seroprevalence to obtain true seroprevalence estimates. Moreover, ignoring clustering of 289 
animals within the herd/flock during sampling will result in inaccurate estimates, given the use of imperfect 290 
diagnostics; herd specificity can be very low when several animals are tested in the same cluster and only one 291 
seropositive result is required for the herd to be classified as positive. Diagnostic specificity may also be low 292 
due to cross-reactive bacteria or vaccination with smooth Brucella strains. 293 
Lack of consideration of the vaccination status of the sampled animals was another reason why some studies 294 
were excluded, because vaccination of livestock against Brucella spp. is practiced in some Middle Eastern 295 
countries and most of the serological tests used are not able to differentiate between vaccinated and infected 296 
animals which can lead to biased estimates. For example two studies estimated the seroprevalence of 297 
brucellosis in sheep in Jordan; the first one was conducted in the Northern governorates and reported a 298 
seroprevalence of 2.2% (95 %CI: 0.5 - 3.5) and 56% (95% CI: 44.0-69.0) at individual animal level and herd 299 
level respectively. The other one reported a seroprevalence at 37.6% and 47% (95% CI: 29, 52) at individual 300 
animal and herd levels respectively, the vaccination status of the sampled flocks was not mentioned in the 301 
second study. As mentioned previously, they may also have an issue of low herd specificity in these studies. 302 
Although a considerable number of studies did not pass the inclusion criteria in this review, they still were 303 
used to provide evidence for the presence of Brucella spp or Brucella seropositivity in different hosts in the 304 
Middle East. These studies provided evidence for Brucella seropositivity in all the countries of the region and 305 
all host species with a few exceptions: lack of evidence of infection in large of small ruminants in Bahrain 306 
(where there is serological evidence of infection in humans) and lack of evidence of infection in large 307 
ruminants in Lebanon and Palestine (where there is evidence of infection in small ruminants and humans).  308 
Such finding is of great importance in adapting collaborative work for the control of brucellosis in the Middle 309 
East. Data extracted from these studies show that B. meletinsis biovars 3, 1 and B. abortus bivars 1, 2, 3 and 9 310 
were the most frequently isolated Brucella spp. in the majority of the Middle East countries. 311 
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Despite the scarcity of sound prevalence or incidence estimates, the review found serological evidence of 312 
Brucella spp. in humans in all countries (Table 1). Isolation of B. abortus from humans only in Israel could be 313 
the result of transmission from cattle to humans before it has been eliminated from the country after adapting 314 
vaccination programme. 315 
Based on our inclusion criteria, only one study provides good quality estimates of the frequency of brucellosis 316 
in humans. It is based on a population-based surveillance implemented in Fayoum Governorate in Egypt in 317 
2002 and 2003. Most studies concerning human infection consisted of case-series describing cases 318 
retrospectively using data from hospital records without a control group – therefore precluding the 319 
investigation of risk factors for infection. Other studies have investigated the prevalence among high risk 320 
subpopulations such as nomadic people or among patients who suffered manifestations compatible with 321 
infection such as women with miscarriage. Such studies were excluded when selection of individuals was not 322 
done probabilistically, although the estimates provided by these studies could be of use and in fact, have been 323 
included in a recently published review on human brucellosis, commissioned by the WHO [54]; the reason for 324 
their inclusion was to fill gaps in some countries to offer frequency estimates to be used in the calculation of 325 
Disability-Adjusted Life Years (DALY) for human brucellosis. 326 
Studies estimating the frequency of brucellosis in humans in the Middle East often rely on the use of records 327 
of public hospitals and primary health centres. Such records depend largely on the clinical presentation of the 328 
disease rather than laboratory confirmation. Furthermore, a considerable number of cases do not seek medical 329 
care or may be referred to private health centres rather than official ones. As a result, such records would 330 
result in estimates that are unreliable. There is a need for population-based surveillance combining clinical 331 
presentations and laboratory confirmation [6].     332 
Although the seroprevalence of brucellosis in ruminants has been intensively investigated across the Middle 333 
East, the current review identified only four studies of sufficient quality reporting seroprevalence in four 334 
ruminant sub-populations; sheep, goats, cattle and buffalos in two countries; Egypt and Jordan [29, 51, 52, 335 
53]. 336 
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The reported seroprevalence varied widely from country to country and even between regions within the same 337 
country. In Egypt, for example, the true seroprevalence at individual animal level in sheep was estimated as 338 
1.16 (95%CI: 1.05-1.27) in seven of Upper Egypt governorates, whereas it was estimated as 12.2% (95%CI: 339 
8.4 - 16.0) in one governorate of the Nile Delta. The results of Upper Egypt study [51] are similar to the 340 
results of the Jordanian study which reported a true seroprevalence of 2.2% (95%CI: 0.5- 3.5) at individual 341 
animal level [29]. Available estimates suggest that brucellosis is endemic at high levels not just among small 342 
ruminants but also in bovine subpopulations in Egypt and reported seroprevalence in Egyptian cattle and 343 
buffalo herds varied between governorates.  344 
This variation in the estimates could result from the heterogeneity of studied populations in terms of 345 
husbandry practices and livestock densities as well as different environmental conditions.  At flock or village 346 
levels the relatively high reported true seroprevalence values in Egypt at 41.3% (95% CI: 26.1–56.7) and in 347 
Jordan at 45% (95% CI: 32- 58) were explained by the authors as possibly the cause of free uncontrolled 348 
movement of sheep flocks between villages, which facilitates contact between infected and susceptible 349 
animals [29], which also has implications for the likely success of control programs. This finding is of high 350 
importance and supports the notion that brucellosis is widespread, at least in some Middle Eastern countries, 351 
with flock-level seroprevalence estimates which are among the highest when compared with endemic 352 
situations reported in other parts of the world. Moreover, animal movement between different countries in the 353 
region and the intense animal movement between the Horn of Africa and the Middle East for trading represent 354 
a challenge for the control and require more collaboration at the international level. 355 
Risk factors for human infection with Brucella spp. can be grouped into two main categories; direct contact 356 
with animals and in particular with abortion or parturition material and consumption of contaminated milk and 357 
dairy products from infected animals.  These high risk practices, coupled with lack of sufficient knowledge of 358 
the disease and absence of effective prevention strategies result in maintenance of the disease in the region. 359 
 360 
In addition, knowledge of farmers and herders regarding the disease and its control is a key factor influencing 361 
the spread of the infection. The similarities in the culture and livestock management practices in the Middle 362 
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Eastern countries mean it may be possible to extrapolate findings with regard to risk factors identified in one 363 
country to other countries.  In Saudi Arabia and Yemen, consumption of raw milk and other dairy products 364 
had a greater effect as a risk factor for human infection compared to direct contact with animals [45, 46]. 365 
Conversely, studies from Iran and Egypt identified direct contact with infected animals to be more strongly 366 
associated with infection [47, 48, 49]. The reason for these differences in the identified risk factors can be 367 
attributed to the nature of the populations under study (e.g. urban vs. rural). Although the number of studies 368 
that fulfil the quality criteria of this review is small, data presented in these studies indicate that ruminant 369 
brucellosis is endemic at high levels in both small and large ruminants in some countries in the Middle East, 370 
such as Egypt and Jordan.  The lack of good quality estimates demonstrates the need for more comprehensive 371 
and well- designed epidemiological studies to bridge the current gap in brucellosis research in the Middle 372 
East; this can be achieved through regional and international collaboration. At the regional level, competent 373 
authorities should develop sustainable surveillance systems, apply strict monitoring programmes on livestock 374 
movement and provide training programmes for both; veterinarians and provincial doctors in the region. 375 
At the international level, technical and financial support should be directed to endemic areas in the world 376 
such as the Middle East.  377 
 378 
CONCLUSIONS 379 
Brucellosis is considered a major public health burden on human populations in the Middle East and available 380 
evidence, although limited, supports this belief. Cases are likely to arise from subpopulations directly exposed 381 
to ruminants or from the consumption of unpasteurized dairy products from infected ruminants, with some 382 
ruminant subpopulations in the region showing among the highest seroprevalence levels when compared to 383 
other endemic regions. Serological and microbiological evidence supports the widespread presence of 384 
Brucella spp. across the region.  However, there is a lack of reliable estimates of the frequency of disease both 385 
in humans and livestock which precludes the formulation of multi-sectorial control policies. There is a need 386 
for well-designed observational studies that could generate reliable frequency estimates needed to assess the 387 
burden of disease and to inform disease control policies. 388 
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Table 1. Microbiological and serological evidence of the presence of Brucella spp. in the Middle East 510 
identified in a systematic review of peer-reviewed journal articles published in English or Arabic 511 
(search conducted on June 2012 and repeated on June 2014). 512 
Country Species (reference) 
Microbiological evidence 
Serological evidence 
B. abortus (biovar) B. melitensis (biovar) 
Bahrain 
Humans (21)  3 yes 
Large ruminants   no 
Small ruminant   no 
Egypt 
Humans(16, 22)  3 yes 
Large ruminants (16,22) 1 3 yes 
Small ruminants (16, 22, 23)  1,3 yes 
Iran 
Humans (24)  Unknown yes 
Large ruminants (24) 2,3, 9 2,3 yes 
Small ruminant (24)   yes 
Iraq 
 
Humans (16)  3 yes 
Large ruminants (25) 2,3,9 1,3 yes 
Small ruminant (7)   yes 
Israel 
Humans (16) 3  yes 
Large ruminants (16) 1, 3  yes 
Small ruminant    
Jordan 
 
Humans (25)  1, 3 yes 
Large ruminants (27, 28)  3 yes 
Small ruminant (30, 31) 9 1,3 yes 
Kuwait 
 
Humans (32) 9 1 yes 
Large ruminants (16)  1 yes 
Small ruminant (16)  1 yes 
Lebanon 
Humans (34)  1 yes 
Large ruminants   no 
Small ruminant (16)  1 yes 
Oman 
Humans (35)  3 yes 
Large ruminants(16) 9  yes 
Small ruminant(16)  3 yes 
Palestine 
Humans  3 yes 
Large ruminants(36)   no 
Small ruminant (36)  3 yes 
Qatar 
 
Humans(37)   yes 
Large ruminants (38)  1 yes 
Small ruminant (16)  1 yes 
Saudi Arabia 
 
Humans (39)  1,2 yes 
Large ruminants (40)  1,2,3 yes 
Small ruminant (16)  2 yes 
Syria 
 
Humans (16)  3 yes 
Large ruminants (41) 9  yes 
Small ruminants    
UAE 
 
Humans (42)  2 yes 
Large ruminants (16) 9 1 yes 
Small ruminant (43)  3 yes 
Yemen 
Humans (44)  3 yes 
Large ruminants (44)   yes 
Small ruminant (44)  3 yes 
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Table 2. Summary of studies on brucellosis the Middle East deemed as relevant and of sufficient quality to be included in this systematic review 
describing the country, year, type of study, diagnostic tests used and the main outcomes obtained. 
Reference Country Year Species Type Tests Main outcome 
5 Egypt 2002, 2003 human Population-based surveillance STA Annual Incidence 
45 Saudi 
Arabia 
1988 human Case- control STA, Coombs Risk factors, OR 
46 Yemen 1991-1993 human Case- control STA Risk factors, OR 
47 Iran 2005 human Case- control STA Risk factors, OR 
48 Egypt 2003 human Case- control RBPT, TAT Risk factors, OR 
49 Egypt 2007 human Case- control STA Risk factors, OR 
50 Jordan 2013 human Case- control  Risk factors, OR 
29 Jordan 200-2001 sheep Cross-sectional RBPT, ELISA TP 
51 Egypt 2008 Cattle, buffalo, 
sheep, goat 
Cross-sectional RBPT, CFT, 
iELISA 
TP 
52 Egypt 2005- 2008 Cattle, buffalo, 
sheep, goat 
Cross-sectional RBPT, CFT TP 
53 Egypt 2009-2010 Cattle, buffalo Cross-sectional iELISA TP 
OR: Odds Ratio; TP: true seroprevalence; STA: Standard Tube Agglutination, RBT: Rose Bengal Test, CFT: Complement Fixation Test, ELISA: 
Enzyme Linked Immnuno-Sorbent Assay, iELISA: indirect ELISA
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Table 3. Summary of studies investigating the seroprevalence of brucellosis in different ruminant sub-populations in the Middle East deemed as relevant and 
of sufficient quality to be included in this systematic review. 
Reference Species Country Level of study 
True seroprevalence %(95% CI) 
Individual level Herd/Flock level 
29 sheep Jordan Governorates 2.2 (95% CI: 0.5 – 3.5) 56 (95% CI: 44 - 69) 
51 Cattle, buffalo, 
sheep, goat 
Egypt Governorate Cattle: 0.79 (95% CI: 0.71-0.87) 
Buffalo: 0.13 (95% CI: 0.08-0.18) 
Sheep: 1.16 (95% CI: 1.05-1.27) 
Goats: 0.44 (95% CI: 0.34-0.54) 
0.2 (95% CI: 0.16 – 0.23) 
52 Cattle, buffalo, 
sheep, goat 
Egypt Governorates Cattle: 12.2 (95% CI: 7.0 - 13.3) 
Buffalo: 12.0 (95% CI: 7.1 - 13.0) 
Sheep: 12.2 (95% CI: 8.4 - 16.0) 
Goats: 11.3 (95% CI: 7.8 - 14.8) 
Cattle: 15.1 (95% CI: 4.0 – 26.2) 
Buffalo: 15.1 (95% CI: 4.0 – 26.2) 
Sheep: 41.3 (95% CI: 26.1 – 56.7) 
Goats: 32.2 (95% CI:17.8 – 46.7) 
53 Cattle and 
buffalo 
Egypt Village 11.0 (95% CI: 3.06 – 18.4) 15.5 (95% CI: 1.44 – 27.9) 
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Table 4.  Risk factors for human brucellosis: summery of case-control studies included in this systematic review. 
 
 
 
 
Reference Country, study population Risk factors (OR, 95% CI) 
45 
Saudi Arabia, 150 cases and 
150 controls 
Consumption of unpasteurised milk (OR: 3.82, 95% CI 2.26-6.46), consumption of buttermilk (laban) 
(OR: 3.1, 95% CI 1.2-7.6) and assisting with animal parturition (OR: 3.6, 95%CI 2.2 – 6.1) 
46 
Yemen, 235 cases  and 234 
controls 
Drinking fresh milk (OR= 2.0, 95% CI: 1.3-4.3), drinking laban (OR= 2.7, 95% CI: 1.7- 4.2), occupation 
as farmers (OR= 2.5, 95% CI: 1.4-4.5), shepherd (OR =7.8, 95% CI: 1.0-61) and microbiologist (OR= 
24.5, 95% CI: 2.9-204) 
47 
Iran, 150 cases  and 150 
matched controls 
Existence of another case of brucellosis in the home (OR= 7.5, 95% CI: 3.9- 14.6) and consumption of 
unpasteurized dairy products (OR= 3.7, 95% CI: 1.6-8.3) 
48 
Egypt, 149 cases and 298 
controls 
Having sheep (OR= 6.2, 95% CI: 1.89 – 20.40), high-risk occupation (OR= 4.4, 95% CI: 1.4-14.5) and 
history of having an aborted animal (OR= 3.5, 95% CI: 1.3 – 9.1) 
49 
Egypt,72 cases and 144  age-
matched controls 
Direct contact with goats (OR=3.2, 95%  CI: 1.2 – 8.7), occupations dealing with animals (OR= 2.4, 95% 
CI: 1.2 – 4.9) and eating ice cream from street venders (OR= 2.4, 95% CI: 1.2 – 4.6) 
50 
Jordan, 56 cases and 247 
matched controls. 
Milking small ruminants (OR= 3.5, 95%CI: 1.5–8.4), consumption of raw feta cheese (OR= 2.8, 95% CI: 
1.4–5.6), consumption of cow’s milk (OR= 0.4, 95% CI: 0.2–0.8) and the consumption of boiled feta 
cheese (OR= 0.4, 95% CI: 0.2-0.8) 
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Fig. 1a Middle East countries with the number of studies per country deemed relevant and of suficient quality to be included in this review in brackets.  b 
Ruminant brucellosis infection and vaccination status in the Middle East countries, data obtained from OIE, 2013. (N: disease not reported; NV: no 
vaccination program).
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Figure 2 Flowchart (template provided by PRISMA) showing the numbers of peer-reviewed journal 
papers at each stage of the systematic review. 
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Screening (451) 
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Quality 
assessment (82) 
 
 
 
 
 
 
 
  
Phase 3 
 Inclusion (11) 
 
82full text articles assessed 
for eligibility 
11 full text articles were 
included in qualitative 
analysis 
71 full text articles excluded: 
 - 13 descriptive case –series 
- 20 unclear study design 
- 13 unrepresentative samples 
- 10 high potential for selection bias; 
- 5 diagnostic tests 
-  10 vaccination status was not 
mentioned 
681 records identified through database 
searching 
369 Records excluded: 
-262 didn’t meet criterion No.1 
-23 didn’t meet criterion No.2 
-84 didn’t meet criterion No.3 
451 records tittle and abstract reviewed 
230 duplicated records 
removed 
